~~<i id='343711D4F8'><strike id='343711D4F8'><tt id='343711D4F8'><pre id='343711D4F8'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

knowledge

author：knowledge 2025-09-06 03:53:07 - browse：564

Martin Shkreli Securities Fraud Trial — Kevin Hagen/Getty Images

Is this the end of the line for the “pharma bro” with the perpetual smirk?

Martin Skhreli was found guilty on Friday of three counts of fraud after a five-week trial in federal court in Brooklyn, N.Y. He faces a prison sentence that could stretch years.

“This was a witch hunt of epic proportions,” Shkreli said outside court after the verdict, the Washington Post reported. “They may have found some broomsticks.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： WHO recommends dropping component of many flu vaccines

entertainment

explore

focus

entertainment

knowledge

MarcTessierLavigne(center)retractedtwoSciencepapersonthedayhisresignationasStanfordpresidenttakeseff

WSS

Complete sequence of Y chromosome published for first time

As pharma fights Medicare drug negotiation, hospitals, docs silent

Australia’s approach to dialysis celebrates life

Australia’s approach to dialysis celebrates life

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Biogen shutters digital health group, ends Apple study, in cost cutting move

hotspot

knowledge

entertainment

Virginia high school admissions case could be legal follow

Winners, losers from Medicare’s list of drugs subject to price talks

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Sudafed saga points to U.S. issues with evaluating older drugs

Medical leaders decry Supreme Court decision on affirmative action

Apellis safety probe of eye disease drug centers on injection needle

Apple is now the first public company to be valued at $3 trillion

FDA seeks to regulate lab

In Memoriam: Notable people who died in 2023

How the Dana

entertainment

Neuroscience startup Neumora files for IPO

FDA seeks to regulate lab

Senator probes 340B programs at Cleveland Clinic, Bon Secours

AstraZeneca bets AAV gene therapy will still deliver the goods

CDC advisory panel says seniors 'may' get RSV vaccine

Why do women spend more than men on medical expenses?

explore

focus

entertainment

knowledge